Variant report
Variant | nsv5747 |
---|---|
Chromosome Location | chr7:53361669-53379389 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:53370596-53370856 | H1-hESC | embryonic stem cell: | n/a | chr7:53370730-53370741 chr7:53370730-53370743 |
2 | CEBPB | chr7:53377863-53378110 | HepG2 | liver: | n/a | chr7:53377942-53377953 |
3 | CTCF | chr7:53365673-53365698 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CTCF | chr7:53377579-53377616 | GM10248 | blood: | n/a | n/a |
5 | GATA2 | chr7:53361458-53361799 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr7:53369813-53369935 | SH-SY5Y | brain: | n/a | n/a |
7 | GATA3 | chr7:53361561-53361761 | SH-SY5Y | brain: | n/a | n/a |
8 | GATA3 | chr7:53374000-53374074 | SH-SY5Y | brain: | n/a | n/a |
9 | GATA3 | chr7:53363940-53364140 | SH-SY5Y | brain: | n/a | n/a |
10 | IRF3 | chr7:53362820-53362826 | GM12878 | blood: | n/a | n/a |
11 | MAFF | chr7:53363292-53363475 | HepG2 | liver: | n/a | n/a |
12 | MXI1 | chr7:53372994-53373072 | Hela-S3 | cervix: | n/a | n/a |
13 | POLR2A | chr7:53373857-53373982 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr7:53365650-53365743 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr7:53374737-53374794 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr7:53369592-53369916 | H1-neurons | neurons: | n/a | n/a |
17 | POLR2A | chr7:53375612-53375616 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr7:53368872-53369072 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr7:53362254-53362454 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | RAD21 | chr7:53365573-53365773 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | RAD21 | chr7:53365521-53365847 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | STAT3 | chr7:53366946-53367146 | MCF10A-Er-Src | breast: | n/a | chr7:53367083-53367097 chr7:53367085-53367094 chr7:53367086-53367095 |
23 | STAT3 | chr7:53376950-53377107 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000271194 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554855577 | chr7:53361670-53361671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570796352 | chr7:53361671-53361672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543557991 | chr7:53361677-53361678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190075045 | chr7:53361680-53361681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563777370 | chr7:53361683-53361684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112973894 | chr7:53361742-53361743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34456955 | chr7:53361746-53361747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs397889011 | chr7:53361753-53361754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577186180 | chr7:53361755-53361756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545768392 | chr7:53361766-53361767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11772242 | chr7:53361788-53361789 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs534593533 | chr7:53361809-53361810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541678094 | chr7:53361874-53361875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561736071 | chr7:53361905-53361906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550506958 | chr7:53361911-53361912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12673892 | chr7:53361949-53361950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34083244 | chr7:53361957-53361958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs397703939 | chr7:53361967-53361968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550418364 | chr7:53361969-53361970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539258619 | chr7:53362078-53362079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11768720 | chr7:53362080-53362081 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs370128736 | chr7:53362101-53362102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532986644 | chr7:53362115-53362116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546617497 | chr7:53362120-53362121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566026461 | chr7:53362125-53362126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74763873 | chr7:53362145-53362146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535348059 | chr7:53362229-53362230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115099046 | chr7:53362240-53362241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143890109 | chr7:53362265-53362266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75131860 | chr7:53362289-53362290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553052765 | chr7:53362308-53362309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62453981 | chr7:53362342-53362343 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs4311623 | chr7:53362395-53362396 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs552955804 | chr7:53362398-53362399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146881198 | chr7:53362409-53362410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186682962 | chr7:53362433-53362434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561981544 | chr7:53362466-53362467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12673526 | chr7:53362473-53362474 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs149020776 | chr7:53362537-53362538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574379489 | chr7:53362546-53362547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142073284 | chr7:53362613-53362614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533050200 | chr7:53362646-53362647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546678826 | chr7:53362652-53362653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191935880 | chr7:53362657-53362658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183734272 | chr7:53362671-53362672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548618714 | chr7:53362699-53362700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62453982 | chr7:53362712-53362713 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs537291726 | chr7:53362719-53362720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189055934 | chr7:53362769-53362770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570668365 | chr7:53362787-53362788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Biliary cancer | 19435499 | CNVD |
Wilms tumour | 21544195 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 22495311 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastric cancer | 24379144 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Ovarian cancer | 18182111 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Barrett''s esophagus | 18559552 | CNVD |
head and neck squamous cell carcinoma | 16943533 | CNVD |
Anaplastic thyroid cancer | 17079354 | CNVD |
Basal-like breast cancer | 17875215 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Colorectal cancer | 18794099 | CNVD |
Gastrointestinal stromal cancer | 17643098 | CNVD |
Lung cancer | 18381415 | CNVD |
Metastatic colorectal cancer | 17664472 | CNVD |
Non-small cell lung cancer | 19255323 | CNVD |
Non-small cell lung cancer | 17673923 | CNVD |
Non-small cell lung cancer | 17975165 | CNVD |
Non-small cell lung cancer | 19622585 | CNVD |
Ovarian cancer | 16607561 | CNVD |
Squamous cell cancer | 19670535 | CNVD |
head and neck squamous cell carcinoma | 16818711 | CNVD |
small cell lung cancer | 18829487 | CNVD |
Breast cancer | 17661082 | CNVD |
Adenocarcinoma | 19260752 | CNVD |
Esophageal cancer | 16575012 | CNVD |
Lung adenocarcinoma | 19138956 | CNVD |
Lung adenocarcinoma | 18379350 | CNVD |
Lung adenocarcinoma | 18258923 | CNVD |
Lung cancer | 19138956 | CNVD |
Lung cancer | 18379350 | CNVD |
Lung cancer | 18258923 | CNVD |
Non-small cell lung cancer | 18304967 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 19260752 | CNVD |
Non-small cell lung cancer | 17079354 | CNVD |
Non-small cell lung cancer | 18559607 | CNVD |
Rectal cancer | 19506820 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
head and neck squamous cell carcinoma | 18813952 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Non-small cell lung cancer | 16943533 | CNVD |
Non-small cell lung cancer | 18509184 | CNVD |
head and neck squamous cell carcinoma | 17538160 | CNVD |
Colorectal cancer | 19712476 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19671679 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:53356000-53371200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr7:53361600-53362800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:53367400-53367600 | Enhancers | Gastric | stomach |
4 | chr7:53369800-53370400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr7:53370000-53370800 | Enhancers | Placenta Amnion | Placenta Amnion |
6 | chr7:53370000-53371000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr7:53370200-53370600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:53370200-53370600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr7:53370200-53370800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr7:53370600-53379000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr7:53371200-53371800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr7:53371600-53371800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr7:53371800-53374600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr7:53371800-53376200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr7:53374600-53374800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr7:53374800-53375000 | Bivalent Enhancer | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr7:53375000-53379000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr7:53376200-53376400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr7:53376400-53378800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr7:53378400-53379200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr7:53378800-53379800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr7:53379000-53379400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
23 | chr7:53379000-53379400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |